5200 Illumina Way
San Diego , CA 92122
San Diego , CA 92122
News
-
Illumina, Inc decreased 4% to $177.53 after the company said in a regulatory filing that the U.S. Securities and Exchange Commission is investigating the company over its acquisition of cancer test developer Grail.
Aug 11, 2023 -
Illumina said revenue in the fourth quarter fell 10% to $1.1 billion and the company swung to a net loss of $140 million from a profit of $112 million or diluted EPS was ($0.89) from $0.71 a year ago.
Feb 8, 2023
Executive/
Director
Links
Price
- Last Close
-
$ 135.99
$ +5.1 3.9 %
Jan 3, 2025
- 52-Week High/Low
- $168.46 - $92.79
- YTD
- 0%
- Trading Volume
- 34,585
- Market Cap Full
- $ 21.6B
- Shares Outstanding
-
158.8M
Nov 6, 2023
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | 33.3% | 8.2% | 3.6% | -5% | 3.8% | -8.2% | 15% | -2.1% | 1.8% | - |
| Q2 | 1.7% | 21.5% | 12.3% | 4% | 23.2% | -47.2% | -19.4% | -19.6% | - | - |
| Q3 | 14.8% | 31.5% | -18.2% | 8% | -14.3% | 3.5% | -26.8% | 9.2% | - | - |
| Q4 | 8% | -18.2% | 8.7% | 19.7% | -6.2% | 6% | 2.1% | -12.3% | - | - |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2025 | 1.8% | - | - | - | - | - | - | - | - | - | - | - |
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -33% | 71% | 37% | 10% | 12% | 3% | -47% | -31% | -4% | 2% | 0% |
Earnings
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Q1 | 0.64 | 1.41 | 1.57 | 1.17 | 1 | 0.55 | 0.02 |
| Q2 | 0.82 | 1.41 | 1.99 | 0.32 | 1.26 | -3.4 | -1.48 |
| Q3 | 1.11 | 1.33 | 1.58 | 1.21 | 2.08 | -24.26 | -4.77 |
| Q4 | 1.44 | 1.41 | 1.6 | 1.75 | 0.71 | -0.89 | - |
| A | 4 | 5.6 | 6.7 | 4.5 | 5 | -28 | -6.23 |
Annual Returns
52 Week
High/Low
Annual
Earnings
Chart
Trading Volume
Outstanding Shares
(In Millions) +
Jan 16, 2024
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Mar | - | 147 | 147 | 145.9 | 157 | 158 |
| Jun | 147 | 147 | 147 | 146 | 157.1 | 158.1 |
| Sep | 147 | 147 | 146 | 146.7 | 157.3 | 158.3 |
| Dec | 147 | 147 | 146 | 156.3 | 157.3 | 158.8 |
SEC Filings
Financial Ratios
| 2022 | 2021 | 2020 | 2019 | 2018 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Management | ||||||||||||||||||
| Inventory / Stock Turnover | 2.8 | 3.2 | 2.8 | 3 | 2.7 | |||||||||||||
| Fixed Asset Turnover | 3 | 3.1 | 2.1 | 2.8 | 2.4 | |||||||||||||
| Total Asset Turnover | 0.4 | 0.3 | 0.4 | 0.5 | 0.5 | |||||||||||||
| Leverage | ||||||||||||||||||
| Debt Ratio | 0.4 | 0.4 | 0.2 | 0.3 | 0.2 | |||||||||||||
| Debt – Equity Ratio | 0.2 | 0.1 | 0.1 | 0.3 | 0.2 | |||||||||||||
| Interest Coverage | -18.6 | 0.1 | -7.6 | -57.9 | 15.5 | |||||||||||||
| Equity multiplier | 0.2 | 0.1 | 0.3 | 0.3 | 0.4 | |||||||||||||